SCHEMBL25704243

SCHEMBL25704243

C=C1C(=O)C2=C(CC(C)C2(C)C)c2ccc3ccccc3c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.38
ALDH1A1 P00352 8/20 0.35
HPGD P15428 7/20 0.35
MAPT P10636 5/20 0.35
KDM4E B2RXH2 4/20 0.35
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
HTT P42858 2/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
NCOA1 Q15788 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
RAB9A P51151 1/20 0.35
LMNA P02545 5/20 0.33
NPSR1 Q6W5P4 2/20 0.33
CYP19A1 P11511 1/20 0.32
CES1 P23141 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8039547 0.89 DNMT1 (0.48) DNMT1ALDH1A1HPGDMAPTKDM4E
SCHEMBL8047458 0.72 DNMT1 (0.40) DNMT1ALDH1A1HPGDMAPTKDM4E
SCHEMBL21189877 0.71 AKT1 (0.43) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL13397736 0.64 DNMT1 (0.61) DNMT1ALDH1A1HPGDMAPTKDM4E
SCHEMBL3331249 0.63 NQO1 (0.50) DNMT1ALDH1A1HPGDMAPTKDM4E
SCHEMBL19230419 0.63 DNMT1 (0.83) DNMT1ALDH1A1HPGDMAPTKDM4E
SCHEMBL3327381 0.62 DNMT1 (0.50) DNMT1ALDH1A1HPGDMAPTKDM4E
SCHEMBL12236188 0.61 DNMT1 (0.67) DNMT1ALDH1A1HPGDMAPTKDM4E
SCHEMBL7122517 0.61 DNMT1 (0.73) DNMT1ALDH1A1HPGDMAPTKDM4E
SCHEMBL16144677 0.61 DNMT1 (0.80) DNMT1ALDH1A1HPGDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4180034-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING NAPHTHOQUINONE-BASED COMPOUND AND IMMUNE CHECKPOINT INHIBITOR AS ACTIVE INGREDIENTS NADIANBIO Ltd. (KR) 2023-05-17 EP disclosed